Andrew Leger, Phd

Andrew Leger, Phd Email and Phone Number

Executive Director and Head of US BD @ QL Biopharmaceutical Co, Ltd
Boston, MA, US
Andrew Leger, Phd's Location
Boston, Massachusetts, United States, United States
About Andrew Leger, Phd

Experienced scientist & business development hybrid with a focus on addressing unmet medical need in patients with rare diseases. Foundational roots in preclinical drug development; currently manage business development activities in specialty disease areas. I bring those skills together to coordinate innovation in rare metabolic, hematologic, pulmonary & neurologic disorders. Subject matter expert in RNA targeting in drug development. Author h-index: 14

Andrew Leger, Phd's Current Company Details
QL Biopharmaceutical Co, Ltd

Ql Biopharmaceutical Co, Ltd

View
Executive Director and Head of US BD
Boston, MA, US
Andrew Leger, Phd Work Experience Details
  • Ql Biopharmaceutical Co, Ltd
    Executive Director And Head Of Us Bd
    Ql Biopharmaceutical Co, Ltd
    Boston, Ma, Us
  • Bioluminescence Ventures
    Venture Partner
    Bioluminescence Ventures Jul 2024 - Present
    San Francisco, California, Us
  • Ferrer
    Head Of Us Business Development
    Ferrer Oct 2021 - Nov 2023
    Barcelona, Es
  • Cambridge Health Alliance
    Senior Director Of Business Development
    Cambridge Health Alliance Dec 2020 - Oct 2021
    Cambridge, Ma, Us
  • Acceleron Pharma
    Director Of Strategy & Business Development
    Acceleron Pharma May 2017 - Dec 2020
    Cambridge, Ma, Us
    Neuromuscular, Hematologic, Metabolic, & Pulmonary Diseases
  • Novartis Institutes For Biomedical Research (Nibr)
    Associate Director, Search & Evaluation, Business Development
    Novartis Institutes For Biomedical Research (Nibr) Jun 2015 - May 2017
    Basel, Baselstadt, Ch
    Pulmonary DisordersMetabolic DiseasesHematologic DisordersExploratory Disease Areas
  • Sanofi Genzyme
    Manager, Strategy & Business Development
    Sanofi Genzyme Nov 2013 - Jun 2015
    Paris, France, Fr
    Managed search & evaluation, triage, due diligence, and licensing efforts pertaining to rare neurologic, hematologic and metabolic disorders.
  • Sanofi Genzyme
    Senior Scientist, Rare Cardiovascular, Neuromuscular & Metabolic Storage Diseases
    Sanofi Genzyme Dec 2006 - Nov 2013
    Paris, France, Fr

Andrew Leger, Phd Education Details

  • Tufts University School Of Medicine
    Tufts University School Of Medicine
    Post-Doctoral Research In Translational Hematology
  • Tufts University School Of Medicine
    Tufts University School Of Medicine
    Biochemistry
  • Cornell University
    Cornell University
    Molecular And Cell Biology

Frequently Asked Questions about Andrew Leger, Phd

What company does Andrew Leger, Phd work for?

Andrew Leger, Phd works for Ql Biopharmaceutical Co, Ltd

What is Andrew Leger, Phd's role at the current company?

Andrew Leger, Phd's current role is Executive Director and Head of US BD.

What schools did Andrew Leger, Phd attend?

Andrew Leger, Phd attended Tufts University School Of Medicine, Tufts University School Of Medicine, Cornell University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.